HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Katavic, V. Articles by Marusic, A. Search for Related Content PubMed PubMed Citation Articles by Katavic, V. Articles by Marusic, A.

Increased Bone Mass Is a Part of the Generalized Lymphoproliferative Disorder Phenotype in the Mouse ^1,2

Vedran Katavi^*, Ivan Kreimir Luki^*, Nataa Kovai^*, Danka Grevi, Joseph A. Lorenzo and Ana Marui^3,*

^* Croatian Institute for Brain Research and Department of Anatomy, Department of Physiology and Immunology, Zagreb University School of Medicine, Zagreb, Croatia; Division of Endocrinology and Metabolism, Department of Medicine, University of Connecticut Health Center, Farmington, CT 06030

We investigated the bone phenotype of mice with generalized lymphoproliferative disorder (gld) due to a defect in the Fas ligand-mediated apoptotic pathway. C57BL/6-gld mice had greater whole body bone mineral density and greater trabecular bone volume than their wild-type controls. gld mice lost 5-fold less trabecular bone and had less osteoclasts on bone surfaces after ovariectomy-induced bone resorption. They also formed more bone in a model of osteogenic regeneration after bone marrow ablation, had less osteoclasts on bone surfaces and less apoptotic osteoblasts. gld and wild-type mice had similar numbers of osteoclasts in bone marrow cultures, but marrow stromal fibroblasts from gld mice formed more alkaline phosphatase-positive colonies. Bone diaphyseal shafts and bone marrow stromal fibroblasts produced more osteoprotegerin mRNA and protein than wild-type mice. These findings provide evidence that the disturbance of the bone system is a part of generalized lymphoproliferative syndrome and indicates the possible role of osteoprotegerin as a regulatory link between the bone and immune system.

Related articles in The JI:

IN THIS ISSUE

The JI 2003 170: 1129-1130. [Full Text]  

This article has been cited by other articles:

				J. Lorenzo, M. Horowitz, and Y. Choi Osteoimmunology: Interactions of the Bone and Immune System Endocr. Rev., June 1, 2008; 29(4): 403 - 440. [Abstract] [Full Text] [PDF]

				N. Kovacic, I. K. Lukic, D. Grcevic, V. Katavic, P. Croucher, and A. Marusic The Fas/Fas Ligand System Inhibits Differentiation of Murine Osteoblasts but Has a Limited Role in Osteoblast and Osteoclast Apoptosis J. Immunol., March 15, 2007; 178(6): 3379 - 3389. [Abstract] [Full Text] [PDF]

				H. Park, Y.-K. Jung, O.-J. Park, Y. J. Lee, J.-Y. Choi, and Y. Choi Interaction of Fas Ligand and Fas Expressed on Osteoclast Precursors Increases Osteoclastogenesis J. Immunol., December 1, 2005; 175(11): 7193 - 7201. [Abstract] [Full Text] [PDF]

				X. Wu, M. A. McKenna, X. Feng, T. R. Nagy, and J. M. McDonald Osteoclast Apoptosis: The Role of Fas in Vivo and in Vitro Endocrinology, December 1, 2003; 144(12): 5545 - 5555. [Abstract] [Full Text] [PDF]

				S.-I. Hayashi, T. Yamada, M. Tsuneto, T. Yamane, M. Takahashi, L. D. Shultz, and H. Yamazaki Distinct Osteoclast Precursors in the Bone Marrow and Extramedullary Organs Characterized by Responsiveness to Toll-Like Receptor Ligands and TNF-{alpha} J. Immunol., November 15, 2003; 171(10): 5130 - 5139. [Abstract] [Full Text] [PDF]